DE69433763D1 - Lineare und cyklische peptide zur behandlung oder verhinderung von ekzem und dermatitis - Google Patents

Lineare und cyklische peptide zur behandlung oder verhinderung von ekzem und dermatitis

Info

Publication number
DE69433763D1
DE69433763D1 DE69433763T DE69433763T DE69433763D1 DE 69433763 D1 DE69433763 D1 DE 69433763D1 DE 69433763 T DE69433763 T DE 69433763T DE 69433763 T DE69433763 T DE 69433763T DE 69433763 D1 DE69433763 D1 DE 69433763D1
Authority
DE
Germany
Prior art keywords
eccem
dermatitis
prevention
linear
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69433763T
Other languages
English (en)
Other versions
DE69433763T2 (de
Inventor
Jurgen Michaelis
Timothy Elliot Trigg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Immuni T Inc
Original Assignee
Advanced Immuni T Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Immuni T Inc filed Critical Advanced Immuni T Inc
Publication of DE69433763D1 publication Critical patent/DE69433763D1/de
Application granted granted Critical
Publication of DE69433763T2 publication Critical patent/DE69433763T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
DE69433763T 1993-09-24 1994-09-26 Lineare und cyklische peptide zur behandlung oder verhinderung von ekzem und dermatitis Expired - Fee Related DE69433763T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPM144993 1993-09-24
AUPM144993 1993-09-24
PCT/AU1994/000574 WO1995008338A1 (en) 1993-09-24 1994-09-26 Method for the treatment or prevention of eczema/dermatitis

Publications (2)

Publication Number Publication Date
DE69433763D1 true DE69433763D1 (de) 2004-06-09
DE69433763T2 DE69433763T2 (de) 2005-04-14

Family

ID=3777229

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69433763T Expired - Fee Related DE69433763T2 (de) 1993-09-24 1994-09-26 Lineare und cyklische peptide zur behandlung oder verhinderung von ekzem und dermatitis

Country Status (9)

Country Link
US (1) US5798335A (de)
EP (1) EP0871466B1 (de)
JP (1) JP3623231B2 (de)
AU (1) AU697847B2 (de)
CA (1) CA2172491A1 (de)
DE (1) DE69433763T2 (de)
DK (1) DK0871466T3 (de)
ES (1) ES2218528T3 (de)
WO (1) WO1995008338A1 (de)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689398A (en) * 1984-06-20 1987-08-25 Ortho Diagnostic Systems Inc. HTLV test using synthetic peptides
US6242564B1 (en) * 1986-06-03 2001-06-05 Candace B. Pert Treatment of tropical spastic paresis with peptide T
US5189022A (en) * 1988-05-27 1993-02-23 The United States Of America As Represented By The Secretary Of Health And Human Services Composition for the treatment of chronic fatigue syndrome
US5063206A (en) * 1988-12-16 1991-11-05 The United States Of Americas As Represented By The Department Of Health And Human Services Compositions having use as treatment of neuropsychiatric deficits
JPH0618777B2 (ja) * 1988-05-27 1994-03-16 アメリカ合衆国 精神神経性欠損症の治療に用いられる組成物
DK31991D0 (da) * 1991-02-25 1991-02-25 Carlbiotech Ltd As Peptid og farmaceutisk praeparat indeholdende et saadant peptid
DK0635027T3 (da) * 1992-03-27 2000-10-02 Advanced Immunit T Inc Peptid T og beslægtede peptider til behandling af inflammation, herunder dissemineret sclerose
US5651993A (en) * 1992-11-18 1997-07-29 Yale University Specific immune system modulation

Also Published As

Publication number Publication date
AU7735094A (en) 1995-04-10
EP0871466A1 (de) 1998-10-21
ES2218528T3 (es) 2004-11-16
WO1995008338A1 (en) 1995-03-30
CA2172491A1 (en) 1995-03-30
AU697847B2 (en) 1998-10-15
JPH09506860A (ja) 1997-07-08
US5798335A (en) 1998-08-25
DE69433763T2 (de) 2005-04-14
EP0871466A4 (de) 1998-11-11
EP0871466B1 (de) 2004-05-06
DK0871466T3 (da) 2004-08-16
JP3623231B2 (ja) 2005-02-23

Similar Documents

Publication Publication Date Title
DE69434540D1 (de) Neurotoxisches Komponente von Botulinumtoxinen zur Behandlung von zervikaler Dystonie
DE69733329D1 (de) Verwendung von Taurin zur Behandlung oder Vorbeugung von ischämischen Verletzungen
DE69432299D1 (de) Multiple Botulinum Toxine zur Behandlung von neuromuskulären Störungen und Zuständen
DE69739758D1 (de) Vakzine zur behandlung von lymphomen und leukämie
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69434476D1 (de) Sensor und methode zur detektion von stickoxiden
DE69318693T2 (de) Magnetischer Konditionierer zur Behandlung von Flüssigkeiten
DE3785388D1 (de) Antivirale peptide und mittel zur behandlung von herpes.
DE58907581D1 (de) Anlage zur bearbeitung und/oder montage von bauteilen.
DE69532066D1 (de) Arzneimittel zur Behandlung von Restenosis und Gefässsklerose
DE69320493T2 (de) Vorrichtung zur erleichterung des anziehens von socken oder dergleichen für behinderte personen
DE69423961D1 (de) Stauchbehandlung von flexiblen warenbahnen
ATA86193A (de) Anlage zur bearbeitung und/oder montage von bauteilen
DE69429101T2 (de) Verbindungen und zusammensetzungen zur behandlung von allergien und entzündungen
DE69625883D1 (de) Zusammensetzung zur Reinigung und/oder Desinfektion von medizinischen Geräten
DE69418931T2 (de) Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten
DE60128009D1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DE69433763D1 (de) Lineare und cyklische peptide zur behandlung oder verhinderung von ekzem und dermatitis
DE69412178T2 (de) Apparat zur Behandlung von Lagen
DE69433817D1 (de) Lineare und cyklische peptide zur behandlung oder vorbeugung der crohn'schen krankheit und/oder der ulzerativen kolitis
ATE224711T1 (de) Formulierung zur behandlung und/oder vorbeugung von dementia
DE69618443T2 (de) Orientieren und fördern von flexiblen oder dünnen gegenständen
DE69203707D1 (de) Verfahren zur Reinigung von Fluorethanen und Chlorfluorethanen.
DE69826460D1 (de) Verwendung von niedermolekularen heparinen zur vorbeugung und behandlung von einem trauma des zentralnervensystems
DE69431103T2 (de) Injizierbares implantat zur behandlungen von falten und hautdepressionen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee